Pfizer Ventures: Investing in Science

Pfizer Ventures: How We Work 

We actively support our current portfolio companies throughout their growth cycles contributing strategic guidance in addition to capital as well as access to Pfizer expertise, when appropriate. 

Overview and Areas of Focus

• Pfizer Ventures invests in areas of current and future strategic interest to Pfizer, with the objective of remaining at the forefront of life science innovation.
• We back companies developing transformative therapeutics across our core focus areas: Oncology; Inflammation & Immunology; Cardiovascular; Metabolic/Obesity; and Vaccines.
• We also invest in platform technology companies with diversified pipelines aligned to Pfizer’s core focus areas, offering multiple pathways for long term value creation.

Investment Strategy

• We invest across the private company lifecycle, from Seed through IPO, with a strong emphasis on early stage new investments.
• We can lead or join investor syndicates and seek board representation commensurate with our level of investment.
• Our typical initial investment ranges from $5–20 million, and we actively support portfolio companies through key value creation milestones, including participation in follow on financings.
• We operate with a streamlined approval process and do not require product or technology rights as a condition of investment.

Advantages of Working With Us

• We partner actively with our portfolio companies throughout their growth, providing strategic and operational guidance alongside capital, and drawing on Pfizer expertise where it can be most impactful.
• Portfolio companies benefit from access to a differentiated network, including scientific leaders, clinical insight, and potential strategic collaborators across the Pfizer ecosystem.
• Each investment maintains the opportunity for a strategic relationship with Pfizer, supporting long‑term value creation while preserving flexibility and independence.